Novartis and Sangamo partner on zinc finger therapies for autism and intellectual disability

Thursday, July 30, 2020 - 12:20 in Health & Medicine

The firms are developing a modified version of the gene-editing technology to boost the expression of genes

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net